Author: chc

FTC to Pharma on Native Advertising: Proceed with Caution

NYTimes: Ban on Drug Ads Would Also Eliminate Ad Benefits

Drug Innovation Success Story: President Carter and Keytruda

Sen. Franken Introduces Legislation to End Drug Advertising Tax Breaks

Jury Says “Not Guilty” to Off-label Charges in Medical Device Case

Best Offense Is a Good Defense When Discussing Drug Pricing

DeLauro's House Bill to Restrict DTC Advertising Likely Would Violate First Amendment

CDER’s Woodcock Says FDA Is Meeting GDUFA Challenges at House Pricing Hearing

Industry More Than Ready for FDA Off-label Communications Guidance